思路迪医药股份(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01244 思路迪医药股份

已收盘 12-23 16:08:41

3.130

-0.200

-6.01%

最高3.330	最低3.110	成交量15.00万
今开3.330	昨收3.330	日振幅6.61%
总市值8.08亿	流通市值8.08亿	总股本2.58亿
成交额48.18万	换手率0.06%	流通股本2.58亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01244","market":"HK","secType":"STK","nameCN":"思路迪医药股份","latestPrice":3.13,"timestamp":1734941321008,"preClose":3.33,"halted":0,"volume":150000,"delay":0,"floatShares":258207000,"shares":258207000,"eps":-2.442162,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.2,"latestTime":"12-23 16:08:41","open":3.33,"high":3.33,"low":3.11,"amount":481795,"amplitude":0.066066,"askPrice":3.33,"askSize":5000,"bidPrice":3.17,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-2.0034705124032453,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735003800000},"adr":0,"listingDate":1671033600000,"adjPreClose":3.33,"openAndCloseTimeList":[[1734917400000,1734926400000],[1734930000000,1734940800000]],"volumeRatio":0.164944,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01244","defaultTab":"news","newsList":[{"id":"2493971731","title":"思路迪医药股份12月23日收盘下跌6.01%，成交48.18万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493971731","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493971731?lang=zh_cn&edition=full","pubTime":"2024-12-23 17:23","pubTimestamp":1734945823,"startTime":"0","endTime":"0","summary":"12月23日，截至港股收盘，恒生指数上涨0.82%，报19883.13点。思路迪医药股份收报3.13港元/股，下跌6.01%，成交量15万股，成交额48.18万港元，振幅6.61%。最近一个月来，思路迪医药股份累计涨幅58.88%，今年来累计跌幅59.03%，跑输恒生指数16.63%的涨幅。财务数据显示，截至2024年6月30日，思路迪医药股份实现营业总收入2.06亿元，同比减少41.45%；归母净利润-1.04亿元，同比增长42.01%；毛利率91.54%，资产负债率38.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223172651a204576f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223172651a204576f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2493782680","title":"思路迪医药股份盘中异动 下午盘股价大跌5.41%报3.150港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493782680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493782680?lang=zh_cn&edition=full","pubTime":"2024-12-23 15:20","pubTimestamp":1734938457,"startTime":"0","endTime":"0","summary":"2024年12月23日下午盘15时20分，思路迪医药股份股票出现波动，股价快速跳水5.41%。截至发稿，该股报3.150港元/股，成交量9.45万股，换手率0.04%，振幅5.41%。资金方面，该股资金流入9945港元，流出24.862万港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。思路迪医药股份股票所在的生物技术行业中，整体涨幅为0.09%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223152058ab8d4476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223152058ab8d4476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2492989804","title":"思路迪医药股份(01244)下跌5.95%，报3.32元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492989804","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492989804?lang=zh_cn&edition=full","pubTime":"2024-12-20 15:40","pubTimestamp":1734680432,"startTime":"0","endTime":"0","summary":"12月20日，思路迪医药股份(01244)盘中下跌5.95%，截至15:40，报3.32元/股，成交100.53万元。思路迪医药股份有限公司主要业务为肿瘤慢病化治疗领域的创新药物的研发和商业化，其产品线包括12款新一代抗肿瘤药物，目前已有8款进入临床开发或商业化阶段。公司还建立了自有mRNA研发平台和肿瘤基因组大数据AI分析平台，用于开发具有差异化临床价值的药物。截至2024年中报，思路迪医药股份营业总收入2.06亿元、净利润-1.04亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/20154046631537.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2492845307","title":"思路迪医药股份盘中异动 早盘股价大跌5.10%报3.350港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492845307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492845307?lang=zh_cn&edition=full","pubTime":"2024-12-20 10:13","pubTimestamp":1734660836,"startTime":"0","endTime":"0","summary":"2024年12月20日早盘10时13分，思路迪医药股份股票出现异动，股价大幅下挫5.10%。截至发稿，该股报3.350港元/股，成交量2.05万股，换手率0.01%，振幅5.10%。资金方面，该股资金流入7060港元，流出5.9445万港元。思路迪医药股份股票所在的生物技术行业中，整体涨幅为0.03%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220101356ab85c771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220101356ab85c771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2492880193","title":"思路迪医药股份盘中异动 快速拉升7.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492880193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492880193?lang=zh_cn&edition=full","pubTime":"2024-12-19 09:32","pubTimestamp":1734571967,"startTime":"0","endTime":"0","summary":"2024年12月19日早盘09时32分，思路迪医药股份股票出现波动，股价急速拉升7.46%。截至发稿，该股报3.600港元/股，成交量10.9万股，换手率0.04%，振幅7.46%。思路迪医药股份股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，科济药业-B、云康集团、思路迪医药股份涨幅较大，振幅较大的相关个股有思路迪医药股份、晶泰控股-P、科济药业-B，振幅分别为7.46%、7.12%、5.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219093249984cbfb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219093249984cbfb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2492192225","title":"思路迪医药股份(01244)下跌5.43%，报2.96元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492192225","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492192225?lang=zh_cn&edition=full","pubTime":"2024-12-18 13:42","pubTimestamp":1734500530,"startTime":"0","endTime":"0","summary":"12月18日，思路迪医药股份(01244)盘中下跌5.43%，截至13:42，报2.96元/股，成交139.86万元。思路迪医药股份有限公司主要业务为肿瘤慢病化治疗领域的创新药物的研发和商业化，其产品线包括12款新一代抗肿瘤药物，目前已有8款进入临床开发或商业化阶段。公司还建立了自有mRNA研发平台和肿瘤基因组大数据AI分析平台，用于开发具有差异化临床价值的药物。截至2024年中报，思路迪医药股份营业总收入2.06亿元、净利润-1.04亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/18134246528158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2492494966","title":"思路迪医药股份盘中异动 早盘股价大涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492494966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492494966?lang=zh_cn&edition=full","pubTime":"2024-12-18 09:30","pubTimestamp":1734485409,"startTime":"0","endTime":"0","summary":"2024年12月18日早盘09时30分，思路迪医药股份股票出现异动，股价快速拉升5.43%。思路迪医药股份股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，思路迪医药股份、和誉-B、再鼎医药涨幅较大，振幅较大的相关个股有晶泰控股-P、再鼎医药、药明生物，振幅分别为2.10%、1.47%、1.31%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121809300995ea3c23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121809300995ea3c23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2492606044","title":"思路迪医药股份(01244)上涨10.58%，报3.45元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492606044","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492606044?lang=zh_cn&edition=full","pubTime":"2024-12-17 11:44","pubTimestamp":1734407098,"startTime":"0","endTime":"0","summary":"12月17日，思路迪医药股份(01244)盘中上涨10.58%，截至11:44，报3.45元/股，成交375.0万元。思路迪医药股份有限公司主要业务为肿瘤慢病化治疗领域的创新药物的研发和商业化，其产品线包括12款新一代抗肿瘤药物，目前已有8款进入临床开发或商业化阶段。公司还建立了自有mRNA研发平台和肿瘤基因组大数据AI分析平台，用于开发具有差异化临床价值的药物。截至2024年中报，思路迪医药股份营业总收入2.06亿元、净利润-1.04亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/17114446460202.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2492067241","title":"思路迪医药股份盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492067241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492067241?lang=zh_cn&edition=full","pubTime":"2024-12-17 09:42","pubTimestamp":1734399728,"startTime":"0","endTime":"0","summary":"2024年12月17日早盘09时42分，思路迪医药股份股票出现波动，股价急速上涨5.13%。截至发稿，该股报3.280港元/股，成交量1.05万股，换手率0.00%，振幅4.81%。思路迪医药股份股票所在的生物技术行业中，整体涨幅为0.02%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217094208a1f471dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217094208a1f471dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2491638289","title":"思路迪医药股份(01244)下跌11.54%，报3.22元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491638289","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491638289?lang=zh_cn&edition=full","pubTime":"2024-12-16 11:30","pubTimestamp":1734319835,"startTime":"0","endTime":"0","summary":"12月16日，思路迪医药股份(01244)盘中下跌11.54%，截至11:30，报3.22元/股，成交115.82万元。思路迪医药股份有限公司主要业务为肿瘤慢病化治疗领域的创新药物的研发和商业化，其产品线包括12款新一代抗肿瘤药物，目前已有8款进入临床开发或商业化阶段。公司还建立了自有mRNA研发平台和肿瘤基因组大数据AI分析平台，用于开发具有差异化临床价值的药物。截至2024年中报，思路迪医药股份营业总收入2.06亿元、净利润-1.04亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/16113046410230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2491684888","title":"思路迪医药股份盘中异动 早盘股价大跌5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491684888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491684888?lang=zh_cn&edition=full","pubTime":"2024-12-16 10:04","pubTimestamp":1734314685,"startTime":"0","endTime":"0","summary":"2024年12月16日早盘10时04分，思路迪医药股份股票出现异动，股价大幅下挫5.77%。截至发稿，该股报3.430港元/股，成交量10.2万股，换手率0.04%，振幅8.52%。资金方面，该股资金流入1.8465万港元，流出30.765万港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。思路迪医药股份股票所在的生物技术行业中，整体跌幅为1.08%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216100445a1f1bd24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216100445a1f1bd24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2491343548","title":"思路迪医药股份12月13日主力资金流入19万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2491343548","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491343548?lang=zh_cn&edition=full","pubTime":"2024-12-13 16:16","pubTimestamp":1734077806,"startTime":"0","endTime":"0","summary":"12月13日, 思路迪医药股份股价涨4.00%，报收3.64元，成交金额1113万元，换手率1.25%，振幅23.71%，量比1.49。思路迪医药股份今日主力资金净流入19万元，连续3日净流入，上一交易日主力净流入288万元，今日环比减少93.40%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为100.00%，平均涨幅为8.45%。该股近5个交易日上涨96.72%，主力资金累计净流入307万元；近20日主力资金累计净流入289万元，其中净流入天数为4日。该股主力净额占比0.02%，港股市场排名125/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213161739ab74c10a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213161739ab74c10a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2491934673","title":"思路迪医药股份(01244)上涨5.14%，报3.68元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491934673","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491934673?lang=zh_cn&edition=full","pubTime":"2024-12-13 09:47","pubTimestamp":1734054424,"startTime":"0","endTime":"0","summary":"12月13日，思路迪医药股份(01244)盘中上涨5.14%，截至09:47，报3.68元/股，成交184.69万元。思路迪医药股份有限公司主要业务为肿瘤慢病化治疗领域的创新药物的研发和商业化，其产品线包括12款新一代抗肿瘤药物，目前已有8款进入临床开发或商业化阶段。公司还建立了自有mRNA研发平台和肿瘤基因组大数据AI分析平台，用于开发具有差异化临床价值的药物。截至2024年中报，思路迪医药股份营业总收入2.06亿元、净利润-1.04亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/13094746345886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2491439827","title":"思路迪医药股份盘中异动 早盘急速跳水7.43%报3.240港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491439827","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491439827?lang=zh_cn&edition=full","pubTime":"2024-12-13 09:32","pubTimestamp":1734053576,"startTime":"0","endTime":"0","summary":"2024年12月13日早盘09时32分，思路迪医药股份股票出现波动，股价快速下跌7.43%。截至发稿，该股报3.240港元/股，成交量9.6万股，换手率0.04%，振幅13.71%。资金方面，该股资金流入3.4665万港元，流出28.808万港元。思路迪医药股份股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，帝王国际投资、圣诺医药-B、科济药业-B涨幅较大，振幅较大的相关个股有晶泰控股-P、思路迪医药股份、科济药业-B，振幅分别为15.14%、13.71%、4.54%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213093256984bae87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213093256984bae87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"1105011366","title":"异动解读 | 思路迪医药股份今日盘中大涨42.15% 主力资金大幅流入成主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1105011366","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105011366?lang=zh_cn&edition=full","pubTime":"2024-12-12 16:26","pubTimestamp":1733992003,"startTime":"0","endTime":"0","summary":"思路迪医药股份(01244)今日盘中股价大涨42.15%,报收3.50港元,成交逾2100万港元,引起市场广泛关注。\n\n推动该股暴涨的主要原因是主力资金大幅流入。数据显示,该股今日主力资金(超大单+大单)净流入288万港元,环比上一交易日大幅增加2518.18%,主力净额占比达0.32%。从资金流向来看,市场似乎看好该股的发展前景,认为其具备较高投资价值。\n\n思路迪医药股份是一家从事生物制药研发及商业化业务的公司,目前已经拥有多个创新药研发管线,包括已在华上市的皮下注射PD-L1抑制剂恩维达。未来公司如果能够推出更多创新药产品,有望获得业绩增长。不过具体原因尚待观察。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 思路迪医药股份今日盘中大涨42.15% 主力资金大幅流入成主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01244"],"gpt_icon":0},{"id":"2490879327","title":"思路迪医药股份12月12日获主力加仓288万元 环比增加2518.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490879327","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490879327?lang=zh_cn&edition=full","pubTime":"2024-12-12 16:15","pubTimestamp":1733991317,"startTime":"0","endTime":"0","summary":"12月12日, 思路迪医药股份股价涨34.10%，报收3.50元，成交金额2151万元，换手率2.56%，振幅50.57%，量比7.41。思路迪医药股份今日主力资金净流入288万元，上一交易日主力净流入11万元，今日环比增加2518.18%。该股近5个交易日上涨92.31%，主力资金累计净流入288万元；近20日主力资金累计净流入253万元，其中净流入天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212161533ab71dddd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212161533ab71dddd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2490284750","title":"思路迪医药股份盘中异动 早盘股价大涨5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490284750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490284750?lang=zh_cn&edition=full","pubTime":"2024-12-12 10:09","pubTimestamp":1733969390,"startTime":"0","endTime":"0","summary":"2024年12月12日早盘10时09分，思路迪医药股份股票出现波动，股价急速上涨5.75%。截至发稿，该股报2.760港元/股，成交量30.9万股，换手率0.12%，振幅10.73%。思路迪医药股份股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，晶泰控股-P、帝王国际投资、思路迪医药股份涨幅较大，振幅较大的相关个股有帝王国际投资、晶泰控股-P、绿竹生物-B，振幅分别为18.75%、12.63%、12.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212100950984b73cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212100950984b73cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2490586005","title":"思路迪医药股份(01244)上涨6.31%，报2.36元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490586005","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490586005?lang=zh_cn&edition=full","pubTime":"2024-12-11 10:49","pubTimestamp":1733885369,"startTime":"0","endTime":"0","summary":"12月11日，思路迪医药股份(01244)盘中上涨6.31%，截至10:49，报2.36元/股，成交100.51万元。思路迪医药股份有限公司主要业务为肿瘤慢病化治疗领域的创新药物的研发和商业化，其产品线包括12款新一代抗肿瘤药物，目前已有8款进入临床开发或商业化阶段。公司还建立了自有mRNA研发平台和肿瘤基因组大数据AI分析平台，用于开发具有差异化临床价值的药物。截至2024年中报，思路迪医药股份营业总收入2.06亿元、净利润-1.04亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/11104946243847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2490907737","title":"思路迪医药股份盘中异动 早盘股价大涨7.21%报2.380港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490907737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490907737?lang=zh_cn&edition=full","pubTime":"2024-12-11 09:35","pubTimestamp":1733880935,"startTime":"0","endTime":"0","summary":"2024年12月11日早盘09时35分，思路迪医药股份股票出现异动，股价快速拉升7.21%。截至发稿，该股报2.380港元/股，成交量4.75万股，换手率0.02%，振幅7.21%。思路迪医药股份股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，云康集团、复旦张江、思路迪医药股份涨幅较大，振幅较大的相关个股有思路迪医药股份、北海康成-B、晶泰控股-P，振幅分别为7.21%、5.63%、5.08%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121109353595e8ce46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121109353595e8ce46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2490039714","title":"思路迪医药股份盘中异动 早盘大幅上涨8.11%报2.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490039714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490039714?lang=zh_cn&edition=full","pubTime":"2024-12-10 09:33","pubTimestamp":1733794380,"startTime":"0","endTime":"0","summary":"2024年12月10日早盘09时33分，思路迪医药股份股票出现波动，股价快速上涨8.11%。截至发稿，该股报2.000港元/股，成交量5.2万股，换手率0.02%，振幅5.95%。资金方面，该股资金流入10.021万港元，流出2000港元。思路迪医药股份股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，药明巨诺-B、思路迪医药股份、贝康医疗-B涨幅较大，振幅较大的相关个股有来凯医药-B、晶泰控股-P、云顶新耀-B，振幅分别为8.29%、7.68%、6.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210093300a1e1ee8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210093300a1e1ee8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3d-medicines.com","stockEarnings":[{"period":"1week","weight":-0.0852},{"period":"1month","weight":0.5708},{"period":"3month","weight":0.5417},{"period":"6month","weight":-0.445},{"period":"1year","weight":-0.5653},{"period":"ytd","weight":-0.5641}],"compareEarnings":[{"period":"1week","weight":-0.0125},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0801},{"period":"6month","weight":0.0939},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1568}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的中国投资控股公司。该公司专注于肿瘤慢病化治疗领域的创新药物发现、开发及商业化，同时布局肿瘤疼痛管理领域。该公司已经构建一套完整的公司内部研发体系，已实现了从药物发现，临床前开发，临床试验、注册的全流程覆盖。该公司第一款上市药物恩维达是一款用于治疗泛瘤种的皮下注射PD-L1抑制剂。该公司还拥有多项创新药研发管线。该公司主要在中国国内市场开展业务。","exchange":"SEHK","name":"思路迪医药股份","nameEN":"3D MEDICINES"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"思路迪医药股份(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供思路迪医药股份(01244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"思路迪医药股份,01244,思路迪医药股份股票,思路迪医药股份股票老虎,思路迪医药股份股票老虎国际,思路迪医药股份行情,思路迪医药股份股票行情,思路迪医药股份股价,思路迪医药股份股市,思路迪医药股份股票价格,思路迪医药股份股票交易,思路迪医药股份股票购买,思路迪医药股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"思路迪医药股份(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供思路迪医药股份(01244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}